Gemtuzumab Chemotherapy MRD Levels; Glasdegib Post-transplant, Adult Untreated, de Novo, Fav Interm Risk AML
Condition: Acute Myeloid Leukemia Interventions: Drug: Glasdegib; Drug: Gemtuzumab Ozogamicin Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials